Auf dem Weg zum Closed-Loop – Ziel und Realität
- 17 May 2017
- journal article
- dossier
- Published by Georg Thieme Verlag KG in Deutsche Medizinische Wochenschrift (1946)
- Vol. 142 (10), 731-736
- https://doi.org/10.1055/s-0042-119492
Abstract
An old dream of patients with type 1 diabetes and medical teams alike is a fully automated insulin therapy. Available sensor-augmented insulin-pumps are able to intervene in insulin therapy by reducing the dose. Aim of several studies is to add an algorithm to the interaction of pump and sensor, so that insulin doses can be regulated fully automatically. Totally closed loop systems are currently not yet available for outpatient use. Hybrid closed loop systems have been approved in the US. They can improve the metabolic status of patients with type 1 diabetes. Risks are similar to sensor-augmented insulin-pump therapy. Patients’ detailed education will continue to be essential for success. Eine vollständig automatisierte Insulindosierung ist der Wunschtraum von Behandlern und Patienten mit Typ-1-Diabetes. Schon jetzt können sensorunterstützte Insulinpumpen reduzierend in die Insulinzufuhr eingreifen. Ziel von Forschungsarbeiten ist es, in das Zusammenspiel aus Pumpe und Sensor einen Algorithmus zu integrieren, der die automatische Abgabe des Insulins im Sinne eines vollständigen Regelkreislaufs (Closed-Loop) reguliert.Keywords
This publication has 10 references indexed in Scilit:
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 DiabetesJAMA, 2016
- Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose ManagementDiabetes Technology & Therapeutics, 2016
- Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trialThe Lancet Diabetes & Endocrinology, 2016
- Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas ProjectsDiabetes Technology & Therapeutics, 2016
- Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysisPediatric Diabetes, 2013
- Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes CampThe New England Journal of Medicine, 2013
- Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump TherapyDiabetes Technology & Therapeutics, 2011
- Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial PancreasDiabetes Care, 2008
- Relationship Between Interstitial And Blood Glucose in Type 1 Diabetes Patients: Delay And The Push-Pull Phenomenon RevisitedDiabetes Technology & Therapeutics, 2007
- The MiniMed Continuous Glucose Monitoring SystemDiabetes Technology & Therapeutics, 2000